Pages that link to "Q33755068"

The following pages link to A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys (Q33755068):

Displaying 39 items.

• The effect of psychostimulants on skeletal health in boys co-treated with risperidone (Q28394992) (← links)
• The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men (Q29247902) (← links)
• Major depressive disorder and bone mass in adolescents and young adults (Q33922382) (← links)
• Serotonin regulates osteoblast proliferation and function in vitro (Q34083546) (← links)
• Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics (Q34127450) (← links)
• Minireview: A skeleton in serotonin's closet? (Q34132327) (← links)
• Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents (Q34143459) (← links)
• Emerging therapeutic opportunities for skeletal restoration (Q34161867) (← links)
• Predictors of Risperidone and 9-Hydroxyrisperidone Serum Concentration in Children and Adolescents (Q34831800) (← links)
• Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. (Q35680962) (← links)
• Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (Q35754726) (← links)
• Propranolol Attenuates Risperidone-Induced Trabecular Bone Loss in Female Mice (Q35763638) (← links)
• SSRIs: bad to the bone? (Q36235126) (← links)
• Correlates of weight gain during long-term risperidone treatment in children and adolescents (Q36373562) (← links)
• Brains, bones, and aging: psychotropic medications and bone health among older adults (Q36427958) (← links)
• Iron Status in Toddlerhood Predicts Sensitivity to Psychostimulants in Children (Q36566387) (← links)
• Iron deficiency in pediatric patients in long-term risperidone treatment (Q36720726) (← links)
• Effect of Fluoxetine Consumption on Orthodontic Tooth Movement in Rats (Q37171940) (← links)
• Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents (Q37247927) (← links)
• Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment (Q37712697) (← links)
• 759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment (Q37719385) (← links)
• Wnt proteins in mineralized tissue development and homeostasis (Q37943458) (← links)
• Bone mineral density in adolescents with eating disorders exposed to selective serotonin reuptake inhibitors (Q38100210) (← links)
• Adverse skeletal effects of drugs - beyond Glucocorticoids (Q38231316) (← links)
• Iron homeostasis during risperidone treatment in children and adolescents. (Q38405415) (← links)
• A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice (Q38660754) (← links)
• Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics. (Q39149871) (← links)
• 9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder (Q39995440) (← links)
• The association between use of antidepressants and bone quality using quantitative heel ultrasound (Q41585462) (← links)
• Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis (Q47557751) (← links)
• Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study (Q47854037) (← links)
• Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis (Q50051605) (← links)
• The Impact of Psychotropic Medications on Bone Health in Youth (Q57151377) (← links)
• Monitoring of prolactin levels in children and adolescents prescribed antipsychotic medication: a complete audit cycle (Q57719664) (← links)
• Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms (Q63381128) (← links)
• Nutrition status, bone mass density, and selective serotonin reuptake inhibitors (Q64124810) (← links)
• Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys (Q85278128) (← links)
• Gut-derived serotonin contributes to bone deficits in colitis (Q90373707) (← links)
• Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study (Q92664528) (← links)